Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is a 26.8% decrease from the number of companies cited in the previous year.
Of the 85 citations issued, the most common citation was 'You did not develop an FSVP'.
Most of the companies cited were involved in the Food and Cosmetics sector. The second most common type of company cited in the time period worked in the the Biologics sector.
Of the companies cited, 28 should take voluntary actions to correct their managing operations (93.3%). Additionally, two companies had to take regulatory and/or administrative actions (6.7%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Aaron Gourmet Food Imports, Inc. | Food and Cosmetics | 06/01/2023 | Very small importer assurances, supplier |
Americord Registry, LLC | Biologics | 01/13/2023 | Approval and review of procedures |
Americord Registry, LLC | Biologics | 01/13/2023 | Validation lacking for sterile drug products |
Americord Registry, LLC | Biologics | 01/13/2023 | Scientifically sound laboratory controls |
Americord Registry, LLC | Biologics | 01/13/2023 | Microbiological testing |
Americord Registry, LLC | Biologics | 01/13/2023 | Dates not included for each significant step |
Americord Registry, LLC | Biologics | 01/13/2023 | Testing, screening, donor eligibility procedures |
Americord Registry, LLC | Biologics | 01/13/2023 | Risk factors, clinical evidence |
Americord Registry, LLC | Biologics | 01/13/2023 | Birth mother sample not tested |
Americord Registry, LLC | Biologics | 01/13/2023 | All core requirements covered in program |
Americord Registry, LLC | Biologics | 01/13/2023 | Deviations--Investigation, documenting, trending |
Americord Registry, LLC | Biologics | 01/13/2023 | Documentation of maintenance and cleaning |
Americord Registry, LLC | Biologics | 01/13/2023 | Verification/validation |
Americord Registry, LLC | Biologics | 01/13/2023 | Process validation procedures |
Americord Registry, LLC | Biologics | 01/13/2023 | Accurate, indelible, legible |
Americord Registry, LLC | Biologics | 01/13/2023 | Records incomplete |
Amorino Trading, LLC | Food and Cosmetics | 03/02/2023 | Develop FSVP |
Applevalley Organics, Corporation, Inc. | Veterinary | 08/16/2023 | Develop FSVP |
Bella Mia Foods, Inc. | Food and Cosmetics | 02/09/2023 | Develop FSVP |
BonBon NYC, LLC. | Food and Cosmetics | 02/24/2023 | Very small importer assurances, supplier |
Eileen's Special Cheesecake, Inc. | Food and Cosmetics | 01/24/2023 | Pest control |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Adequate control, proper conditions |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Use prior to verification |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Accurate, indelible, legible |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records incomplete |
Eye Bank For Sight Restoration, Inc. | Biologics | 11/13/2023 | Records maintained concurrently |
G21 USA, Inc. | Devices | 07/25/2023 | Training - Lack of or inadequate procedures |
G21 USA, Inc. | Devices | 07/25/2023 | Lack of or inadequate procedures |
G21 USA, Inc. | Devices | 07/25/2023 | Lack of or inadequate complaint procedures |
Island Reproductive Services | Biologics | 01/26/2023 | Design of procedures to ensure compliance |
Island Reproductive Services | Biologics | 01/26/2023 | Determination based on screening and testing |
Island Reproductive Services | Biologics | 01/26/2023 | Summary--records used to make determination |
Island Reproductive Services | Biologics | 01/26/2023 | Accurate, indelible, legible |
Island Reproductive Services | Biologics | 01/26/2023 | Risk factors, clinical evidence |
J&H Imports Services Corporation | Food and Cosmetics | 08/02/2023 | Develop FSVP |
Juice Press, LLC | Food and Cosmetics | 03/14/2023 | Develop FSVP |
Kofinas Fertility Group | Biologics | 07/25/2023 | Determination based on screening and testing |
Kofinas Fertility Group | Biologics | 07/25/2023 | Responsible person to determine, document |
Kofinas Fertility Group | Biologics | 07/25/2023 | Accurate, indelible, legible |
LA Dulceria, Inc. | Food and Cosmetics | 02/08/2023 | Develop FSVP |
Manhattan Fertility Services, LLC | Biologics | 04/06/2023 | Labeled re: biohazard, risks, test results |
Manhattan Fertility Services, LLC | Biologics | 04/06/2023 | Risk factors, clinical evidence |
Mrinal M. Gounder, M.D. | Drugs | 03/03/2023 | FD-1572, protocol compliance |
Mrinal M. Gounder, M.D. | Drugs | 03/03/2023 | Safety Reports - Serious Events |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | ClincialTrials.gov statement |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Prompt reporting of unanticipated problems |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Prompt reporting of noncompliance |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Members present for review |
N. Y. S. Psychiatric Institute IRB | Drugs | 02/02/2023 | Minor changes |
New Hope Fertility Center | Biologics | 03/03/2023 | Responsible person to determine, document |
New Hope Fertility Center | Biologics | 03/03/2023 | Completion of eligibility determination |
New Hope Fertility Center | Biologics | 03/03/2023 | Eligibility not required--warning labels |
New York Blood Center Donor Center of NYBC, Inc. | Biologics | 03/30/2023 | Establish, maintain and follow manufacturing SOPs |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Maintenance - tracing |
New York Blood Center Enterprises | Biologics | 07/06/2023 | When to report |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Following manufacturer's instructions |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Establish, maintain and follow manufacturing SOPs |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Thorough investigations |
New York Blood Center Enterprises | Biologics | 07/06/2023 | Required records |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Equipment observed, standardized, calibrated |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Establish, maintain and follow manufacturing SOPs |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Concurrent documentation |
New York Presbyterian Hospital-Columbia University Med. Center | Biologics | 11/28/2023 | Required records |
Pinnacle Fertility Labs New York | Biologics | 12/14/2023 | Testing, screening, donor eligibility procedures |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Prevention of contamination |
Ports America, Inc. | Food and Cosmetics | 10/10/2023 | Signs for non-potable water |
Shneiders USA, Inc. | Food and Cosmetics | 01/19/2023 | Develop FSVP |
Simple Foods of Staten Island, Inc. | Food and Cosmetics | 01/10/2023 | HACCP plan implementation |
Simple Foods of Staten Island, Inc. | Food and Cosmetics | 01/10/2023 | Records values/observations |
Simple Foods of Staten Island, Inc. | Food and Cosmetics | 01/10/2023 | Verification - record review - frequency |
Simple Foods of Staten Island, Inc. | Food and Cosmetics | 01/10/2023 | Verification - corrective action |
Simple Foods of Staten Island, Inc. | Food and Cosmetics | 01/10/2023 | Sanitation monitoring |
Simple Foods of Staten Island, Inc. | Food and Cosmetics | 01/10/2023 | Importer verification |
Sojitz Corporation of America | Veterinary | 08/11/2023 | Develop FSVP |
Sojitz Corporation of America | Veterinary | 08/11/2023 | Record - translate to English |
TMRW Life Sciences, Inc. | Devices | 10/24/2023 | DHR - not or inadequately maintained |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Cleaning and sanitizing substances - Safe and adequate |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Manufacturing, processing, packing, holding - Controls |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Calibration - adequacy |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Plumbing design, installation, maintenance |
Wako Inflight Service, Inc. | Food and Cosmetics | 03/01/2023 | Maintained in good repair |
Xin Ao International Group / Xin Ao Properties Usa Lius Group, Corp. | Food and Cosmetics | 05/22/2023 | Develop FSVP |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design changes - Lack of or Inadequate Procedures |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Design history file |
Xtreem Pulse, LLC | Devices | 10/13/2023 | Lack of or inadequate receiving acceptance procedures |